Travere Therapeutics Inc (TVTX) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Travere Therapeutics Inc   (NASDAQ: TVTX)
 

Travere Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Travere Therapeutics Inc 's inventory turnover ratio sequentially decreased to 0.57 in the second quarter 2026, unsurprisingly, as the Travere Therapeutics Inc markets continue to deteriorate, and TVTX's faces growing challenges to bring down its inventories. Travere Therapeutics Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 640 days, from 263 days, in the Mar 31 2026 quarter.

Within Healthcare sector 349 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1198 in the first quarter 2026, to 1730.

TVTX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Travere Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?




TVTX Inventory Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 879.19 % 61.65 % -5.24 % -12.71 % -31.56 %
Y / Y Cost of Sales Growth 42.93 % -58.32 % 0.04 % -2.52 % -26.2 %
Inventory Turnover Ratio (TTM) 0.57 1.39 2.13 2.09 2.02
TVTX's Total Ranking # 1730 # 1198 # 1062 # 1291 # 882
Average inventory processing period 639 262 172 175 181
Seq. Inventory Growth 530.1 % 8.19 % 5.89 % 35.65 % 4.02 %
Seq. Cost of Sales Growth 11.49 % -23.65 % 61.14 % 4.21 % -67.49 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 109
Healthcare Sector # 350
Overall Market # 1730

Inventory Turnover Ratio Statistics
High Average Low
3.85 1.21 0.57
(Dec 31 2014)   (Jun 30 2026)




Financial Statements
Travere Therapeutics Inc 's Inventories $ 40 Millions Visit TVTX's Balance sheet
Travere Therapeutics Inc 's Cost of Revenues TTM $ 8 Millions Visit TVTX's Income Statement
What are TVTX's Sales? Visit TVTX's Sales by Segment

Other Inventory Turnover Ratios
Travere Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TVTX's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TVTX's Competitors
Inventory Turnover Ratio for TVTX's Suppliers
Inventory Turnover Ratio for TVTX's Customers

You may also want to know
TVTX's Sales Growth Rates TVTX's Pe Price to earnings ratio TVTX's Receivables Turnover Ratio TVTX's Stock Quote
TVTX's Net Income Growth Rates TVTX's Ps Price to Sales ratio TVTX's Sales per Employee TVTX's Asset Turnover Ratio
TVTX's Net Margin TVTX's Pb Price to Book ratio TVTX's Financial Strength Ratios TVTX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Biomarin Pharmaceutical Inc  0.57 $ 813.588  Millions$ 1,434  Millions
Verastem Inc   0.54 $ 1.128  Millions$ 2  Millions
Ionis Pharmaceuticals Inc   0.53 $ 9.873  Millions$ 19  Millions
Heron Therapeutics Inc   0.53 $ 45.572  Millions$ 86  Millions
Orchestra Biomed Holdings Inc   0.52 $ 0.157  Millions$ 0  Millions
Sintx Technologies Inc   0.51 $ 0.627  Millions$ 1  Millions
Siga Technologies Inc  0.50 $ 24.494  Millions$ 49  Millions
Ardelyx inc   0.50 $ 25.401  Millions$ 51  Millions
Orthopediatrics Corp  0.49 $ 65.142  Millions$ 134  Millions
Scienture Holdings Inc   0.47 $ 0.101  Millions$ 0  Millions
Co diagnostics Inc   0.44 $ 0.412  Millions$ 1  Millions
Immunitybio inc   0.43 $ 1.095  Millions$ 3  Millions
Pelthos Therapeutics Inc   0.40 $ 9.271  Millions$ 23  Millions
EBR Systems, Inc.  0.39 $ 5.514  Millions$ 14  Millions
Aspire Biopharma Holdings Inc   0.34 $ 0.080  Millions$ 0  Millions
Guided Therapeutics Inc   0.32 $ 0.158  Millions$ 1  Millions
Invo Fertility Inc   0.29 $ 0.065  Millions$ 0  Millions
Outlook Therapeutics Inc   0.26 $ 0.985  Millions$ 4  Millions
Alpha Cognition Inc.  0.23 $ 1.250  Millions$ 6  Millions
Verrica Pharmaceuticals Inc   0.17 $ 0.400  Millions$ 2  Millions
Nexalin Technology Inc   0.17 $ 0.030  Millions$ 0  Millions
Femasys Inc   0.15 $ 0.898  Millions$ 6  Millions
Yubo International Biotech Limited  0.15 $ 0.004  Millions$ 0  Millions
Bioadaptives Inc   0.14 $ 0.006  Millions$ 0  Millions
Citius Pharmaceuticals Inc   0.07 $ 1.610  Millions$ 22  Millions
Adagio Medical Holdings inc   0.05 $ 0.089  Millions$ 2  Millions

Date modified: 2026-09-08T15:11:45+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.